OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
1-Year Est. Return 7.48%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-7.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$58.3M
AUM Growth
-$5.97M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1
+$259K
2
+$255K
3
+$246K
4
NKTR icon
Nektar Therapeutics
NKTR
+$73.7K
5
LGND icon
Ligand Pharmaceuticals
LGND
+$43.2K

Top Sells

1
+$506K
2
+$409K
3
+$408K
4
RUBY
Rubius Therapeutics, Inc
RUBY
+$391K
5
WVE icon
Wave Life Sciences
WVE
+$377K

Sector Composition

1 Healthcare 64.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
51
IQVIA
IQV
$27.7B
$319K 0.55%
1,985
CRL icon
52
Charles River Laboratories
CRL
$7.65B
$300K 0.51%
2,112
GRFS icon
53
Grifois
GRFS
$5.32B
$278K 0.48%
13,196
+114
GILD icon
54
Gilead Sciences
GILD
$180B
$276K 0.47%
4,082
+415
BIIB icon
55
Biogen
BIIB
$26.6B
$263K 0.45%
+1,123
AMGN icon
56
Amgen
AMGN
$197B
$257K 0.44%
1,397
+155
NBIX icon
57
Neurocrine Biosciences
NBIX
$13B
$254K 0.44%
3,012
+205
EXEL icon
58
Exelixis
EXEL
$10.7B
$244K 0.42%
11,440
LGND icon
59
Ligand Pharmaceuticals
LGND
$4.05B
$241K 0.41%
3,384
+587
AGIO icon
60
Agios Pharmaceuticals
AGIO
$1.63B
$240K 0.41%
4,806
KYNB
61
Kyntra Bio
KYNB
$28.2M
$221K 0.38%
195
+2
SCTL
62
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$115K 0.2%
12,659
ACIU icon
63
AC Immune
ACIU
$304M
– –
-39,801
UTHR icon
64
United Therapeutics
UTHR
$23.5B
– –
-2,199
ALKS icon
65
Alkermes
ALKS
$4.63B
– –
-7,722
CLLS
66
Cellectis
CLLS
$344M
– –
-22,309
CTMX icon
67
CytomX Therapeutics
CTMX
$793M
– –
-25,284
PGEN icon
68
Precigen
PGEN
$1.24B
– –
-32,284
RGNX icon
69
Regenxbio
RGNX
$442M
– –
-8,832
SGMO icon
70
Sangamo Therapeutics
SGMO
$141M
– –
-33,529
SUPN icon
71
Supernus Pharmaceuticals
SUPN
$2.87B
– –
-11,648
WVE icon
72
Wave Life Sciences
WVE
$2.45B
– –
-9,716
XNCR icon
73
Xencor
XNCR
$880M
– –
-10,935
SURF
74
DELISTED
Surface Oncology, Inc. Common Stock
SURF
– –
-53,063
RUBY
75
DELISTED
Rubius Therapeutics, Inc
RUBY
– –
-21,610
1 2
3